These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15359831)

  • 1. [Chronic hepatitis C: virologic and immunologic aspects].
    Moriya K; Koike K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):405-7. PubMed ID: 15359831
    [No Abstract]   [Full Text] [Related]  

  • 2. [Involvement of dendritic cell dysfunction in the persistence of hepatitis C virus infection].
    Kanto T; Hayashi N
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):170-4. PubMed ID: 15359787
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunomodulating effect of HCV during the development of chronic hepatitis C: toward new therapeutic approaches].
    Stoll-Keller F; Schvoerer E; Thumann C; Navas MC; Aubertin AM
    Bull Acad Natl Med; 2003; 187(6):1147-60; discussion 1160-1. PubMed ID: 14978874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1-TH2 cytokine profile in subjects with self-limited disease.
    Gigi E; Raptopoulou-Gigi M; Kalogeridis A; Masiou S; Orphanou E; Vrettou E; Lalla TH; Sinakos E; Tsapas V
    J Viral Hepat; 2008 Feb; 15(2):145-54. PubMed ID: 18184198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th1 and Th2 cytokines are elevated in HCV-infected SVR(-) patients treated with interferon-alpha.
    Wan L; Kung YJ; Lin YJ; Liao CC; Sheu JJ; Tsai Y; Lai HC; Peng CY; Tsai FJ
    Biochem Biophys Res Commun; 2009 Feb; 379(4):855-60. PubMed ID: 19118522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activity of cytokines in chronic HCV-infected patients].
    Lapiński TW; Dabrowska MM
    Przegl Epidemiol; 2007; 61(4):747-54. PubMed ID: 18572507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered innate immunity in chronic hepatitis C infection: cause or effect?
    Szabo G; Chang S; Dolganiuc A
    Hepatology; 2007 Oct; 46(4):1279-90. PubMed ID: 17886338
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study on the relationship between the serum levels of Th1/Th2 cytokines and the clinical manifestations of chronic hepatitis C and the outcome of interferon therapy].
    Zhang L; Miao L; Liu JF; Fu HC; Ma L; Zhao GZ; Dou XG
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2009 Oct; 23(5):352-4. PubMed ID: 20387484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection.
    Miyatake H; Kanto T; Inoue M; Sakakibara M; Kaimori A; Yakushijin T; Itose I; Miyazaki M; Kuzushita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Viral Hepat; 2007 Jun; 14(6):404-12. PubMed ID: 17501761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential use of Toll-like receptor agonists to restore the dysfunctional immunity induced by hepatitis C virus.
    Salem ML; El-Demellawy M; El-Azm AR
    Cell Immunol; 2010; 262(2):96-104. PubMed ID: 20338549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of peripheral blood CD4-positive T cells to carcinogenesis in patients with HCV-related chronic hepatitis and liver cirrhosis.
    Matsui T; Nagai H; Sumino Y; Miki K
    Cancer Chemother Pharmacol; 2008 Aug; 62(3):401-6. PubMed ID: 17932673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence.
    Hiroishi K; Ito T; Imawari M
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1473-82. PubMed ID: 18761560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The heterogeneity of HCV quasi-species in the hypervariable region and its relationship to interferon therapy].
    Shi LL; Zhang L; Zhao GZ; Qiao GY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):523, 527. PubMed ID: 16042890
    [No Abstract]   [Full Text] [Related]  

  • 14. Innate immunity and chronic immune activation in HCV/HIV-1 co-infection.
    Gonzalez VD; Landay AL; Sandberg JK
    Clin Immunol; 2010 Apr; 135(1):12-25. PubMed ID: 20100670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus (HCV): a review of immunological aspects.
    Irshad M; Khushboo I; Singh S; Singh S
    Int Rev Immunol; 2008; 27(6):497-517. PubMed ID: 19065353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes.
    Brady MT; MacDonald AJ; Rowan AG; Mills KH
    Eur J Immunol; 2003 Dec; 33(12):3448-57. PubMed ID: 14635055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-viral immune responses against hepatitis C virus].
    Imawari M
    Uirusu; 2002 Jun; 52(1):151-6. PubMed ID: 12227166
    [No Abstract]   [Full Text] [Related]  

  • 18. [Relationship between the dynamics of cytokines and the phenotypes of the disease in chronic HCV infection].
    Okumura A; Kakumu S
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):164-9. PubMed ID: 15359786
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection.
    Kanto T; Inoue M; Miyatake H; Sato A; Sakakibara M; Yakushijin T; Oki C; Itose I; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Infect Dis; 2004 Dec; 190(11):1919-26. PubMed ID: 15529255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the effect of IL-12 therapy on immunoregulatory T-cell subsets in patients with chronic hepatitis C infection.
    Barth H; Klein R; Berg PA; Wiedenmann B; Hopf U; Berg T
    Hepatogastroenterology; 2003; 50(49):201-6. PubMed ID: 12630023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.